US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.761
  • -0.042-5.20%
Close Dec 13 16:00 ET
  • 0.750
  • -0.011-1.39%
Post 19:42 ET
68.91MMarket Cap-0.41P/E (TTM)

Verrica Pharmaceuticals Key Stats

Verrica Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.109M--
--2024/Q4-- / 710.330K--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.109M--
--2024/Q4-- / 710.330K--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--

Unlock Free Earnings Estimates

Verrica Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Hold

  • Buy

    20.00%
  • Hold

    80.00%
  • Sell

    0.00%

Price Target

No Data